Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
05 12 2022
Historique:
received: 10 06 2022
revised: 02 08 2022
accepted: 01 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: ppublish

Résumé

Individuals who receive a third mRNA vaccine dose show enhanced protection against severe COVID-19, but little is known about the impact of breakthrough infections on memory responses. Here, we examine the memory antibodies that develop after a third or fourth antigenic exposure by Delta or Omicron BA.1 infection, respectively. A third exposure to antigen by Delta breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a third mRNA vaccine dose. A fourth antigenic exposure with Omicron BA.1 infection increased variant-specific plasma antibody and memory B cell responses. However, the fourth exposure did not increase the overall frequency of memory B cells or their general potency or breadth compared to a third mRNA vaccine dose. In conclusion, a third antigenic exposure by Delta infection elicits strain-specific memory responses and increases in the overall potency and breadth of the memory B cells. In contrast, the effects of a fourth antigenic exposure with Omicron BA.1 are limited to increased strain-specific memory with little effect on the potency or breadth of memory B cell antibodies. The results suggest that the effect of strain-specific boosting on memory B cell compartment may be limited.

Identifiants

pubmed: 36149398
pii: 213497
doi: 10.1084/jem.20221006
pmc: PMC9513381
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
RNA, Messenger 0
Vaccines, Synthetic 0
mRNA Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI165075
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI138938
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI064003
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111825
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI078788
Pays : United States

Informations de copyright

© 2022 Wang et al.

Références

Elife. 2020 Oct 28;9:
pubmed: 33112236
Immunity. 2021 Aug 10;54(8):1853-1868.e7
pubmed: 34331873
Mol Biol Evol. 2018 May 1;35(5):1253-1265
pubmed: 29474671
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
Nature. 2022 Feb;602(7898):654-656
pubmed: 35016196
Nature. 2022 Mar 4;:
pubmed: 35246640
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
N Engl J Med. 2022 Feb 10;386(6):599-601
pubmed: 35030645
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Cell. 2022 Apr 28;185(9):1539-1548.e5
pubmed: 35429436
Cell. 2021 Mar 4;184(5):1201-1213.e14
pubmed: 33571429
JCI Insight. 2022 Oct 10;7(19):
pubmed: 36214224
N Engl J Med. 2022 Jul 7;387(1):86-88
pubmed: 35731894
Sci Immunol. 2022 Jul 29;7(73):eabq3511
pubmed: 35549299
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
Lancet. 2022 Feb 12;399(10325):625-626
pubmed: 35063123
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Annu Rev Immunol. 2022 Apr 26;40:413-442
pubmed: 35113731
Nature. 2021 Dec;600(7889):517-522
pubmed: 34619745
Science. 2022 Nov 11;378(6620):619-627
pubmed: 36264829
Cell. 2022 Feb 3;185(3):467-484.e15
pubmed: 35081335
Nature. 2022 Aug;608(7923):593-602
pubmed: 35714668
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288661
Sci Immunol. 2022 Sep 16;7(75):eabq2427
pubmed: 35653438
N Engl J Med. 2022 Feb 3;386(5):492-494
pubmed: 34965337
Nature. 2019 Feb;566(7744):398-402
pubmed: 30760926
Cell. 2021 Apr 15;184(8):2201-2211.e7
pubmed: 33743891
Cell. 2022 Jun 9;185(12):2116-2131.e18
pubmed: 35662412
Bioinformatics. 2015 Oct 15;31(20):3356-8
pubmed: 26069265
Cell. 2021 Aug 5;184(16):4220-4236.e13
pubmed: 34242578
Front Immunol. 2019 Oct 09;10:2365
pubmed: 31649674
Nat Commun. 2022 Nov 11;13(1):6856
pubmed: 36369151
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Lancet. 2022 Jan 29;399(10323):412-413
pubmed: 35065007
Cell Host Microbe. 2022 Jun 8;30(6):880-886.e4
pubmed: 35436444
Open Forum Infect Dis. 2022 May 07;9(7):ofac227
pubmed: 35818364
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
N Engl J Med. 2022 Apr 7;386(14):1314-1326
pubmed: 35196424
Nature. 2021 Jul;595(7867):426-431
pubmed: 34126625
Nature. 2022 Jul;607(7917):128-134
pubmed: 35447027
Cell. 2022 May 26;185(11):1875-1887.e8
pubmed: 35523182

Auteurs

Zijun Wang (Z)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Pengcheng Zhou (P)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Frauke Muecksch (F)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Alice Cho (A)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Tarek Ben Tanfous (T)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Marie Canis (M)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Leander Witte (L)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Brianna Johnson (B)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Raphael Raspe (R)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Fabian Schmidt (F)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Eva Bednarski (E)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Justin Da Silva (J)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Victor Ramos (V)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Shuai Zong (S)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Martina Turroja (M)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Katrina G Millard (KG)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Kai-Hui Yao (KH)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Irina Shimeliovich (I)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Juan Dizon (J)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Anna Kaczynska (A)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Mila Jankovic (M)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Anna Gazumyan (A)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Thiago Y Oliveira (TY)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Marina Caskey (M)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Christian Gaebler (C)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.

Paul D Bieniasz (PD)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.
Howard Hughes Medical Institute, Chevy Chase, MD.

Theodora Hatziioannou (T)

Laboratory of Retrovirology, The Rockefeller University, New York, NY.

Michel C Nussenzweig (MC)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.
Howard Hughes Medical Institute, Chevy Chase, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH